nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—Irinotecan—colon cancer	0.0681	0.468	CbGbCtD
Ropivacaine—CYP1A2—Fluorouracil—colon cancer	0.0383	0.263	CbGbCtD
Ropivacaine—CYP3A4—Irinotecan—colon cancer	0.0209	0.144	CbGbCtD
Ropivacaine—CYP3A4—Vincristine—colon cancer	0.0183	0.126	CbGbCtD
Ropivacaine—Lidocaine—EGFR—colon cancer	0.00726	0.767	CrCbGaD
Ropivacaine—Lidocaine—ABCB1—colon cancer	0.00221	0.233	CrCbGaD
Ropivacaine—Respiratory failure—Methotrexate—colon cancer	0.00208	0.00247	CcSEcCtD
Ropivacaine—Urethral disorder—Vincristine—colon cancer	0.00208	0.00246	CcSEcCtD
Ropivacaine—Purpura—Capecitabine—colon cancer	0.00207	0.00245	CcSEcCtD
Ropivacaine—Rhinitis—Irinotecan—colon cancer	0.00207	0.00245	CcSEcCtD
Ropivacaine—Pulmonary embolism—Methotrexate—colon cancer	0.00205	0.00242	CcSEcCtD
Ropivacaine—Osteoarthritis—Capecitabine—colon cancer	0.002	0.00236	CcSEcCtD
Ropivacaine—Rhinitis—Fluorouracil—colon cancer	0.00198	0.00235	CcSEcCtD
Ropivacaine—Depressed level of consciousness—Methotrexate—colon cancer	0.00198	0.00234	CcSEcCtD
Ropivacaine—Cardiac disorder—Vincristine—colon cancer	0.00197	0.00233	CcSEcCtD
Ropivacaine—Hypoaesthesia—Fluorouracil—colon cancer	0.00197	0.00233	CcSEcCtD
Ropivacaine—Cardiac disorder—Irinotecan—colon cancer	0.00192	0.00227	CcSEcCtD
Ropivacaine—Urinary retention—Capecitabine—colon cancer	0.0019	0.00225	CcSEcCtD
Ropivacaine—Cardiac arrest—Capecitabine—colon cancer	0.0019	0.00225	CcSEcCtD
Ropivacaine—Mood swings—Capecitabine—colon cancer	0.00189	0.00224	CcSEcCtD
Ropivacaine—Coma—Methotrexate—colon cancer	0.00187	0.00221	CcSEcCtD
Ropivacaine—Mental disorder—Vincristine—colon cancer	0.00186	0.0022	CcSEcCtD
Ropivacaine—Chills—Irinotecan—colon cancer	0.00185	0.00219	CcSEcCtD
Ropivacaine—Arrhythmia—Irinotecan—colon cancer	0.00184	0.00218	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Capecitabine—colon cancer	0.00182	0.00216	CcSEcCtD
Ropivacaine—Hypokalaemia—Capecitabine—colon cancer	0.00182	0.00215	CcSEcCtD
Ropivacaine—Breast disorder—Capecitabine—colon cancer	0.0018	0.00214	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.0018	0.00213	CcSEcCtD
Ropivacaine—Back pain—Vincristine—colon cancer	0.00178	0.00211	CcSEcCtD
Ropivacaine—Arrhythmia—Fluorouracil—colon cancer	0.00177	0.00209	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00176	0.00208	CcSEcCtD
Ropivacaine—Back pain—Irinotecan—colon cancer	0.00174	0.00206	CcSEcCtD
Ropivacaine—Abdominal distension—Capecitabine—colon cancer	0.00174	0.00206	CcSEcCtD
Ropivacaine—Muscle spasms—Irinotecan—colon cancer	0.00173	0.00204	CcSEcCtD
Ropivacaine—Erythema—Fluorouracil—colon cancer	0.00172	0.00204	CcSEcCtD
Ropivacaine—Anaemia—Vincristine—colon cancer	0.0017	0.00202	CcSEcCtD
Ropivacaine—Bronchospasm—Capecitabine—colon cancer	0.0017	0.00201	CcSEcCtD
Ropivacaine—Agitation—Vincristine—colon cancer	0.0017	0.00201	CcSEcCtD
Ropivacaine—Sweating increased—Capecitabine—colon cancer	0.00168	0.00199	CcSEcCtD
Ropivacaine—Ill-defined disorder—Irinotecan—colon cancer	0.00167	0.00197	CcSEcCtD
Ropivacaine—Anaemia—Irinotecan—colon cancer	0.00166	0.00197	CcSEcCtD
Ropivacaine—Vertigo—Vincristine—colon cancer	0.00166	0.00196	CcSEcCtD
Ropivacaine—Vision blurred—Fluorouracil—colon cancer	0.00162	0.00192	CcSEcCtD
Ropivacaine—Malaise—Irinotecan—colon cancer	0.00162	0.00192	CcSEcCtD
Ropivacaine—Vertigo—Irinotecan—colon cancer	0.00161	0.00191	CcSEcCtD
Ropivacaine—Dysuria—Capecitabine—colon cancer	0.00161	0.00191	CcSEcCtD
Ropivacaine—Syncope—Irinotecan—colon cancer	0.00161	0.00191	CcSEcCtD
Ropivacaine—Convulsion—Vincristine—colon cancer	0.0016	0.00189	CcSEcCtD
Ropivacaine—Hypertension—Vincristine—colon cancer	0.00159	0.00188	CcSEcCtD
Ropivacaine—Anaemia—Fluorouracil—colon cancer	0.00159	0.00188	CcSEcCtD
Ropivacaine—Loss of consciousness—Irinotecan—colon cancer	0.00158	0.00187	CcSEcCtD
Ropivacaine—Myalgia—Vincristine—colon cancer	0.00157	0.00186	CcSEcCtD
Ropivacaine—Cough—Irinotecan—colon cancer	0.00157	0.00186	CcSEcCtD
Ropivacaine—Hyperglycaemia—Capecitabine—colon cancer	0.00156	0.00184	CcSEcCtD
Ropivacaine—Hypertension—Irinotecan—colon cancer	0.00155	0.00184	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Methotrexate—colon cancer	0.00154	0.00182	CcSEcCtD
Ropivacaine—Depression—Capecitabine—colon cancer	0.00153	0.00182	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Capecitabine—colon cancer	0.00152	0.0018	CcSEcCtD
Ropivacaine—Discomfort—Irinotecan—colon cancer	0.00151	0.00179	CcSEcCtD
Ropivacaine—Myocardial infarction—Capecitabine—colon cancer	0.00151	0.00178	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Capecitabine—colon cancer	0.00151	0.00178	CcSEcCtD
Ropivacaine—Anaphylactic shock—Vincristine—colon cancer	0.00151	0.00178	CcSEcCtD
Ropivacaine—Jaundice—Capecitabine—colon cancer	0.0015	0.00177	CcSEcCtD
Ropivacaine—Infection—Vincristine—colon cancer	0.0015	0.00177	CcSEcCtD
Ropivacaine—Urinary tract infection—Capecitabine—colon cancer	0.0015	0.00177	CcSEcCtD
Ropivacaine—Convulsion—Fluorouracil—colon cancer	0.00149	0.00176	CcSEcCtD
Ropivacaine—Osteoarthritis—Methotrexate—colon cancer	0.00149	0.00176	CcSEcCtD
Ropivacaine—Confusional state—Irinotecan—colon cancer	0.00148	0.00175	CcSEcCtD
Ropivacaine—Thrombocytopenia—Vincristine—colon cancer	0.00147	0.00174	CcSEcCtD
Ropivacaine—Haematuria—Capecitabine—colon cancer	0.00147	0.00174	CcSEcCtD
Ropivacaine—Anaphylactic shock—Irinotecan—colon cancer	0.00147	0.00174	CcSEcCtD
Ropivacaine—Chest pain—Fluorouracil—colon cancer	0.00146	0.00173	CcSEcCtD
Ropivacaine—Myalgia—Fluorouracil—colon cancer	0.00146	0.00173	CcSEcCtD
Ropivacaine—Infection—Irinotecan—colon cancer	0.00146	0.00172	CcSEcCtD
Ropivacaine—Hyperhidrosis—Vincristine—colon cancer	0.00146	0.00172	CcSEcCtD
Ropivacaine—Discomfort—Fluorouracil—colon cancer	0.00145	0.00171	CcSEcCtD
Ropivacaine—Shock—Irinotecan—colon cancer	0.00144	0.00171	CcSEcCtD
Ropivacaine—Thrombocytopenia—Irinotecan—colon cancer	0.00144	0.0017	CcSEcCtD
Ropivacaine—Hyperhidrosis—Irinotecan—colon cancer	0.00142	0.00168	CcSEcCtD
Ropivacaine—Confusional state—Fluorouracil—colon cancer	0.00142	0.00168	CcSEcCtD
Ropivacaine—Mood swings—Methotrexate—colon cancer	0.00141	0.00167	CcSEcCtD
Ropivacaine—Hypotension—Vincristine—colon cancer	0.00141	0.00166	CcSEcCtD
Ropivacaine—Bradycardia—Capecitabine—colon cancer	0.00141	0.00166	CcSEcCtD
Ropivacaine—Anaphylactic shock—Fluorouracil—colon cancer	0.0014	0.00166	CcSEcCtD
Ropivacaine—Infection—Fluorouracil—colon cancer	0.00139	0.00165	CcSEcCtD
Ropivacaine—Rhinitis—Capecitabine—colon cancer	0.00138	0.00164	CcSEcCtD
Ropivacaine—Thrombocytopenia—Fluorouracil—colon cancer	0.00137	0.00163	CcSEcCtD
Ropivacaine—Hypoaesthesia—Capecitabine—colon cancer	0.00137	0.00163	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00137	0.00162	CcSEcCtD
Ropivacaine—Tachycardia—Fluorouracil—colon cancer	0.00137	0.00162	CcSEcCtD
Ropivacaine—Hypotension—Irinotecan—colon cancer	0.00137	0.00162	CcSEcCtD
Ropivacaine—Urinary tract disorder—Capecitabine—colon cancer	0.00136	0.00161	CcSEcCtD
Ropivacaine—Insomnia—Vincristine—colon cancer	0.00136	0.00161	CcSEcCtD
Ropivacaine—Oedema peripheral—Capecitabine—colon cancer	0.00136	0.00161	CcSEcCtD
Ropivacaine—Urethral disorder—Capecitabine—colon cancer	0.00135	0.0016	CcSEcCtD
Ropivacaine—Paraesthesia—Vincristine—colon cancer	0.00135	0.0016	CcSEcCtD
Ropivacaine—Breast disorder—Methotrexate—colon cancer	0.00134	0.00159	CcSEcCtD
Ropivacaine—Insomnia—Irinotecan—colon cancer	0.00133	0.00157	CcSEcCtD
Ropivacaine—Paraesthesia—Irinotecan—colon cancer	0.00132	0.00156	CcSEcCtD
Ropivacaine—Hypotension—Fluorouracil—colon cancer	0.00131	0.00155	CcSEcCtD
Ropivacaine—Dyspnoea—Irinotecan—colon cancer	0.00131	0.00155	CcSEcCtD
Ropivacaine—Somnolence—Irinotecan—colon cancer	0.0013	0.00154	CcSEcCtD
Ropivacaine—Dyspepsia—Irinotecan—colon cancer	0.00129	0.00153	CcSEcCtD
Ropivacaine—Tinnitus—Capecitabine—colon cancer	0.00129	0.00152	CcSEcCtD
Ropivacaine—Constipation—Vincristine—colon cancer	0.00129	0.00152	CcSEcCtD
Ropivacaine—Pain—Vincristine—colon cancer	0.00129	0.00152	CcSEcCtD
Ropivacaine—Cardiac disorder—Capecitabine—colon cancer	0.00128	0.00152	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00128	0.00151	CcSEcCtD
Ropivacaine—Insomnia—Fluorouracil—colon cancer	0.00127	0.0015	CcSEcCtD
Ropivacaine—Paraesthesia—Fluorouracil—colon cancer	0.00126	0.00149	CcSEcCtD
Ropivacaine—Pain—Irinotecan—colon cancer	0.00125	0.00148	CcSEcCtD
Ropivacaine—Constipation—Irinotecan—colon cancer	0.00125	0.00148	CcSEcCtD
Ropivacaine—Dyspnoea—Fluorouracil—colon cancer	0.00125	0.00148	CcSEcCtD
Ropivacaine—Somnolence—Fluorouracil—colon cancer	0.00125	0.00148	CcSEcCtD
Ropivacaine—Chills—Capecitabine—colon cancer	0.00124	0.00147	CcSEcCtD
Ropivacaine—Dyspepsia—Fluorouracil—colon cancer	0.00124	0.00146	CcSEcCtD
Ropivacaine—Arrhythmia—Capecitabine—colon cancer	0.00123	0.00146	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Vincristine—colon cancer	0.00123	0.00146	CcSEcCtD
Ropivacaine—Mental disorder—Capecitabine—colon cancer	0.00121	0.00143	CcSEcCtD
Ropivacaine—Feeling abnormal—Irinotecan—colon cancer	0.00121	0.00143	CcSEcCtD
Ropivacaine—Erythema—Capecitabine—colon cancer	0.0012	0.00142	CcSEcCtD
Ropivacaine—Dysuria—Methotrexate—colon cancer	0.0012	0.00142	CcSEcCtD
Ropivacaine—Pain—Fluorouracil—colon cancer	0.0012	0.00142	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Irinotecan—colon cancer	0.0012	0.00142	CcSEcCtD
Ropivacaine—Body temperature increased—Vincristine—colon cancer	0.00119	0.00141	CcSEcCtD
Ropivacaine—Abdominal pain—Vincristine—colon cancer	0.00119	0.00141	CcSEcCtD
Ropivacaine—Back pain—Capecitabine—colon cancer	0.00116	0.00138	CcSEcCtD
Ropivacaine—Body temperature increased—Irinotecan—colon cancer	0.00116	0.00137	CcSEcCtD
Ropivacaine—Abdominal pain—Irinotecan—colon cancer	0.00116	0.00137	CcSEcCtD
Ropivacaine—Feeling abnormal—Fluorouracil—colon cancer	0.00116	0.00137	CcSEcCtD
Ropivacaine—Muscle spasms—Capecitabine—colon cancer	0.00116	0.00137	CcSEcCtD
Ropivacaine—Drowsiness—Methotrexate—colon cancer	0.00115	0.00136	CcSEcCtD
Ropivacaine—Depression—Methotrexate—colon cancer	0.00114	0.00135	CcSEcCtD
Ropivacaine—Vision blurred—Capecitabine—colon cancer	0.00113	0.00134	CcSEcCtD
Ropivacaine—Tremor—Capecitabine—colon cancer	0.00113	0.00133	CcSEcCtD
Ropivacaine—Ill-defined disorder—Capecitabine—colon cancer	0.00112	0.00132	CcSEcCtD
Ropivacaine—Urticaria—Fluorouracil—colon cancer	0.00112	0.00132	CcSEcCtD
Ropivacaine—Anaemia—Capecitabine—colon cancer	0.00111	0.00132	CcSEcCtD
Ropivacaine—Body temperature increased—Fluorouracil—colon cancer	0.00111	0.00131	CcSEcCtD
Ropivacaine—Hypersensitivity—Vincristine—colon cancer	0.00111	0.00131	CcSEcCtD
Ropivacaine—Haematuria—Methotrexate—colon cancer	0.00109	0.00129	CcSEcCtD
Ropivacaine—Malaise—Capecitabine—colon cancer	0.00108	0.00128	CcSEcCtD
Ropivacaine—Vertigo—Capecitabine—colon cancer	0.00108	0.00128	CcSEcCtD
Ropivacaine—Hypersensitivity—Irinotecan—colon cancer	0.00108	0.00128	CcSEcCtD
Ropivacaine—Asthenia—Vincristine—colon cancer	0.00108	0.00128	CcSEcCtD
Ropivacaine—Syncope—Capecitabine—colon cancer	0.00108	0.00128	CcSEcCtD
Ropivacaine—Loss of consciousness—Capecitabine—colon cancer	0.00106	0.00125	CcSEcCtD
Ropivacaine—Asthenia—Irinotecan—colon cancer	0.00105	0.00125	CcSEcCtD
Ropivacaine—Cough—Capecitabine—colon cancer	0.00105	0.00124	CcSEcCtD
Ropivacaine—Hypertension—Capecitabine—colon cancer	0.00104	0.00123	CcSEcCtD
Ropivacaine—Hypersensitivity—Fluorouracil—colon cancer	0.00103	0.00122	CcSEcCtD
Ropivacaine—Diarrhoea—Vincristine—colon cancer	0.00103	0.00122	CcSEcCtD
Ropivacaine—Arthralgia—Capecitabine—colon cancer	0.00102	0.00121	CcSEcCtD
Ropivacaine—Myalgia—Capecitabine—colon cancer	0.00102	0.00121	CcSEcCtD
Ropivacaine—Chest pain—Capecitabine—colon cancer	0.00102	0.00121	CcSEcCtD
Ropivacaine—Anxiety—Capecitabine—colon cancer	0.00102	0.00121	CcSEcCtD
Ropivacaine—Urinary tract disorder—Methotrexate—colon cancer	0.00102	0.0012	CcSEcCtD
Ropivacaine—Discomfort—Capecitabine—colon cancer	0.00101	0.0012	CcSEcCtD
Ropivacaine—Urethral disorder—Methotrexate—colon cancer	0.00101	0.00119	CcSEcCtD
Ropivacaine—Diarrhoea—Irinotecan—colon cancer	0.001	0.00119	CcSEcCtD
Ropivacaine—Dizziness—Vincristine—colon cancer	0.000995	0.00118	CcSEcCtD
Ropivacaine—Pruritus—Fluorouracil—colon cancer	0.000993	0.00118	CcSEcCtD
Ropivacaine—Confusional state—Capecitabine—colon cancer	0.000989	0.00117	CcSEcCtD
Ropivacaine—Infection—Capecitabine—colon cancer	0.000975	0.00115	CcSEcCtD
Ropivacaine—Dizziness—Irinotecan—colon cancer	0.000969	0.00115	CcSEcCtD
Ropivacaine—Shock—Capecitabine—colon cancer	0.000965	0.00114	CcSEcCtD
Ropivacaine—Diarrhoea—Fluorouracil—colon cancer	0.000961	0.00114	CcSEcCtD
Ropivacaine—Thrombocytopenia—Capecitabine—colon cancer	0.000961	0.00114	CcSEcCtD
Ropivacaine—Tinnitus—Methotrexate—colon cancer	0.000959	0.00113	CcSEcCtD
Ropivacaine—Tachycardia—Capecitabine—colon cancer	0.000958	0.00113	CcSEcCtD
Ropivacaine—Vomiting—Vincristine—colon cancer	0.000957	0.00113	CcSEcCtD
Ropivacaine—Cardiac disorder—Methotrexate—colon cancer	0.000954	0.00113	CcSEcCtD
Ropivacaine—Skin disorder—Capecitabine—colon cancer	0.000953	0.00113	CcSEcCtD
Ropivacaine—Rash—Vincristine—colon cancer	0.000949	0.00112	CcSEcCtD
Ropivacaine—Hyperhidrosis—Capecitabine—colon cancer	0.000949	0.00112	CcSEcCtD
Ropivacaine—Dermatitis—Vincristine—colon cancer	0.000948	0.00112	CcSEcCtD
Ropivacaine—Headache—Vincristine—colon cancer	0.000943	0.00112	CcSEcCtD
Ropivacaine—Vomiting—Irinotecan—colon cancer	0.000932	0.0011	CcSEcCtD
Ropivacaine—Dizziness—Fluorouracil—colon cancer	0.000928	0.0011	CcSEcCtD
Ropivacaine—Rash—Irinotecan—colon cancer	0.000924	0.00109	CcSEcCtD
Ropivacaine—Dermatitis—Irinotecan—colon cancer	0.000924	0.00109	CcSEcCtD
Ropivacaine—Chills—Methotrexate—colon cancer	0.000922	0.00109	CcSEcCtD
Ropivacaine—Headache—Irinotecan—colon cancer	0.000918	0.00109	CcSEcCtD
Ropivacaine—Hypotension—Capecitabine—colon cancer	0.000917	0.00109	CcSEcCtD
Ropivacaine—Mental disorder—Methotrexate—colon cancer	0.000901	0.00107	CcSEcCtD
Ropivacaine—Erythema—Methotrexate—colon cancer	0.000895	0.00106	CcSEcCtD
Ropivacaine—Nausea—Vincristine—colon cancer	0.000894	0.00106	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000894	0.00106	CcSEcCtD
Ropivacaine—Vomiting—Fluorouracil—colon cancer	0.000893	0.00106	CcSEcCtD
Ropivacaine—Insomnia—Capecitabine—colon cancer	0.000887	0.00105	CcSEcCtD
Ropivacaine—Rash—Fluorouracil—colon cancer	0.000885	0.00105	CcSEcCtD
Ropivacaine—Dermatitis—Fluorouracil—colon cancer	0.000884	0.00105	CcSEcCtD
Ropivacaine—Paraesthesia—Capecitabine—colon cancer	0.000881	0.00104	CcSEcCtD
Ropivacaine—Headache—Fluorouracil—colon cancer	0.00088	0.00104	CcSEcCtD
Ropivacaine—Dyspnoea—Capecitabine—colon cancer	0.000875	0.00104	CcSEcCtD
Ropivacaine—Nausea—Irinotecan—colon cancer	0.000871	0.00103	CcSEcCtD
Ropivacaine—Back pain—Methotrexate—colon cancer	0.000866	0.00102	CcSEcCtD
Ropivacaine—Dyspepsia—Capecitabine—colon cancer	0.000864	0.00102	CcSEcCtD
Ropivacaine—Vision blurred—Methotrexate—colon cancer	0.000843	0.000998	CcSEcCtD
Ropivacaine—Constipation—Capecitabine—colon cancer	0.000839	0.000993	CcSEcCtD
Ropivacaine—Pain—Capecitabine—colon cancer	0.000839	0.000993	CcSEcCtD
Ropivacaine—Nausea—Fluorouracil—colon cancer	0.000834	0.000987	CcSEcCtD
Ropivacaine—Ill-defined disorder—Methotrexate—colon cancer	0.00083	0.000983	CcSEcCtD
Ropivacaine—Anaemia—Methotrexate—colon cancer	0.000827	0.000979	CcSEcCtD
Ropivacaine—Feeling abnormal—Capecitabine—colon cancer	0.000809	0.000957	CcSEcCtD
Ropivacaine—Malaise—Methotrexate—colon cancer	0.000807	0.000955	CcSEcCtD
Ropivacaine—Vertigo—Methotrexate—colon cancer	0.000804	0.000952	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Capecitabine—colon cancer	0.000802	0.00095	CcSEcCtD
Ropivacaine—Cough—Methotrexate—colon cancer	0.000781	0.000924	CcSEcCtD
Ropivacaine—Urticaria—Capecitabine—colon cancer	0.000779	0.000923	CcSEcCtD
Ropivacaine—Abdominal pain—Capecitabine—colon cancer	0.000776	0.000918	CcSEcCtD
Ropivacaine—Body temperature increased—Capecitabine—colon cancer	0.000776	0.000918	CcSEcCtD
Ropivacaine—Convulsion—Methotrexate—colon cancer	0.000775	0.000918	CcSEcCtD
Ropivacaine—Chest pain—Methotrexate—colon cancer	0.000762	0.000902	CcSEcCtD
Ropivacaine—Myalgia—Methotrexate—colon cancer	0.000762	0.000902	CcSEcCtD
Ropivacaine—Arthralgia—Methotrexate—colon cancer	0.000762	0.000902	CcSEcCtD
Ropivacaine—Discomfort—Methotrexate—colon cancer	0.000753	0.000891	CcSEcCtD
Ropivacaine—Confusional state—Methotrexate—colon cancer	0.000736	0.000872	CcSEcCtD
Ropivacaine—Anaphylactic shock—Methotrexate—colon cancer	0.00073	0.000865	CcSEcCtD
Ropivacaine—Infection—Methotrexate—colon cancer	0.000726	0.000859	CcSEcCtD
Ropivacaine—Hypersensitivity—Capecitabine—colon cancer	0.000723	0.000856	CcSEcCtD
Ropivacaine—Thrombocytopenia—Methotrexate—colon cancer	0.000715	0.000847	CcSEcCtD
Ropivacaine—Skin disorder—Methotrexate—colon cancer	0.000709	0.00084	CcSEcCtD
Ropivacaine—Hyperhidrosis—Methotrexate—colon cancer	0.000706	0.000836	CcSEcCtD
Ropivacaine—Asthenia—Capecitabine—colon cancer	0.000704	0.000833	CcSEcCtD
Ropivacaine—Pruritus—Capecitabine—colon cancer	0.000694	0.000822	CcSEcCtD
Ropivacaine—Hypotension—Methotrexate—colon cancer	0.000683	0.000808	CcSEcCtD
Ropivacaine—Diarrhoea—Capecitabine—colon cancer	0.000671	0.000795	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000665	0.000788	CcSEcCtD
Ropivacaine—Insomnia—Methotrexate—colon cancer	0.000661	0.000782	CcSEcCtD
Ropivacaine—Paraesthesia—Methotrexate—colon cancer	0.000656	0.000776	CcSEcCtD
Ropivacaine—Dyspnoea—Methotrexate—colon cancer	0.000651	0.000771	CcSEcCtD
Ropivacaine—Somnolence—Methotrexate—colon cancer	0.000649	0.000769	CcSEcCtD
Ropivacaine—Dizziness—Capecitabine—colon cancer	0.000649	0.000768	CcSEcCtD
Ropivacaine—Dyspepsia—Methotrexate—colon cancer	0.000643	0.000761	CcSEcCtD
Ropivacaine—Pain—Methotrexate—colon cancer	0.000625	0.000739	CcSEcCtD
Ropivacaine—Vomiting—Capecitabine—colon cancer	0.000624	0.000738	CcSEcCtD
Ropivacaine—Rash—Capecitabine—colon cancer	0.000619	0.000732	CcSEcCtD
Ropivacaine—Dermatitis—Capecitabine—colon cancer	0.000618	0.000732	CcSEcCtD
Ropivacaine—Headache—Capecitabine—colon cancer	0.000615	0.000728	CcSEcCtD
Ropivacaine—Feeling abnormal—Methotrexate—colon cancer	0.000602	0.000712	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Methotrexate—colon cancer	0.000597	0.000707	CcSEcCtD
Ropivacaine—Nausea—Capecitabine—colon cancer	0.000583	0.00069	CcSEcCtD
Ropivacaine—Urticaria—Methotrexate—colon cancer	0.00058	0.000687	CcSEcCtD
Ropivacaine—Body temperature increased—Methotrexate—colon cancer	0.000577	0.000683	CcSEcCtD
Ropivacaine—Abdominal pain—Methotrexate—colon cancer	0.000577	0.000683	CcSEcCtD
Ropivacaine—Hypersensitivity—Methotrexate—colon cancer	0.000538	0.000637	CcSEcCtD
Ropivacaine—Asthenia—Methotrexate—colon cancer	0.000524	0.00062	CcSEcCtD
Ropivacaine—Pruritus—Methotrexate—colon cancer	0.000517	0.000612	CcSEcCtD
Ropivacaine—Diarrhoea—Methotrexate—colon cancer	0.0005	0.000592	CcSEcCtD
Ropivacaine—Dizziness—Methotrexate—colon cancer	0.000483	0.000572	CcSEcCtD
Ropivacaine—Vomiting—Methotrexate—colon cancer	0.000464	0.00055	CcSEcCtD
Ropivacaine—Rash—Methotrexate—colon cancer	0.000461	0.000545	CcSEcCtD
Ropivacaine—Dermatitis—Methotrexate—colon cancer	0.00046	0.000545	CcSEcCtD
Ropivacaine—Headache—Methotrexate—colon cancer	0.000458	0.000542	CcSEcCtD
Ropivacaine—Nausea—Methotrexate—colon cancer	0.000434	0.000514	CcSEcCtD
